Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: E9AFC1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 132 | 136 | PF00656 | 0.429 |
CLV_PCSK_SKI1_1 | 152 | 156 | PF00082 | 0.591 |
CLV_PCSK_SKI1_1 | 354 | 358 | PF00082 | 0.465 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.420 |
CLV_PCSK_SKI1_1 | 93 | 97 | PF00082 | 0.434 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.617 |
DOC_CYCLIN_RxL_1 | 90 | 97 | PF00134 | 0.477 |
DOC_CYCLIN_yCln2_LP_2 | 358 | 364 | PF00134 | 0.429 |
DOC_MAPK_gen_1 | 321 | 331 | PF00069 | 0.432 |
DOC_PP2B_LxvP_1 | 358 | 361 | PF13499 | 0.596 |
DOC_USP7_MATH_1 | 115 | 119 | PF00917 | 0.546 |
DOC_USP7_MATH_1 | 168 | 172 | PF00917 | 0.705 |
DOC_USP7_MATH_1 | 179 | 183 | PF00917 | 0.591 |
DOC_USP7_MATH_1 | 362 | 366 | PF00917 | 0.680 |
DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.363 |
DOC_WW_Pin1_4 | 152 | 157 | PF00397 | 0.684 |
DOC_WW_Pin1_4 | 202 | 207 | PF00397 | 0.628 |
DOC_WW_Pin1_4 | 360 | 365 | PF00397 | 0.630 |
DOC_WW_Pin1_4 | 79 | 84 | PF00397 | 0.407 |
LIG_14-3-3_CanoR_1 | 107 | 112 | PF00244 | 0.336 |
LIG_14-3-3_CanoR_1 | 146 | 156 | PF00244 | 0.495 |
LIG_Actin_WH2_2 | 342 | 359 | PF00022 | 0.410 |
LIG_AP2alpha_1 | 133 | 137 | PF02296 | 0.414 |
LIG_BRCT_BRCA1_1 | 13 | 17 | PF00533 | 0.514 |
LIG_BRCT_BRCA1_1 | 362 | 366 | PF00533 | 0.446 |
LIG_FHA_1 | 178 | 184 | PF00498 | 0.572 |
LIG_FHA_1 | 195 | 201 | PF00498 | 0.638 |
LIG_FHA_1 | 234 | 240 | PF00498 | 0.370 |
LIG_FHA_1 | 82 | 88 | PF00498 | 0.376 |
LIG_FHA_2 | 32 | 38 | PF00498 | 0.473 |
LIG_FHA_2 | 341 | 347 | PF00498 | 0.552 |
LIG_LIR_Apic_2 | 26 | 32 | PF02991 | 0.500 |
LIG_LIR_Gen_1 | 22 | 32 | PF02991 | 0.509 |
LIG_LIR_Gen_1 | 236 | 246 | PF02991 | 0.319 |
LIG_LIR_Nem_3 | 110 | 114 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.525 |
LIG_LIR_Nem_3 | 236 | 241 | PF02991 | 0.367 |
LIG_NRBOX | 274 | 280 | PF00104 | 0.377 |
LIG_NRBOX | 90 | 96 | PF00104 | 0.480 |
LIG_Pex14_2 | 133 | 137 | PF04695 | 0.370 |
LIG_Pex14_2 | 25 | 29 | PF04695 | 0.493 |
LIG_SH2_SRC | 312 | 315 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 111 | 114 | PF00017 | 0.349 |
LIG_SH2_STAT5 | 312 | 315 | PF00017 | 0.325 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.453 |
LIG_SH3_3 | 160 | 166 | PF00018 | 0.695 |
LIG_SH3_3 | 358 | 364 | PF00018 | 0.472 |
LIG_SUMO_SIM_anti_2 | 326 | 333 | PF11976 | 0.468 |
LIG_TRAF2_1 | 192 | 195 | PF00917 | 0.696 |
LIG_TRAF2_1 | 373 | 376 | PF00917 | 0.732 |
LIG_TRFH_1 | 111 | 115 | PF08558 | 0.357 |
LIG_UBA3_1 | 278 | 282 | PF00899 | 0.346 |
LIG_UBA3_1 | 66 | 73 | PF00899 | 0.401 |
LIG_UBA3_1 | 74 | 81 | PF00899 | 0.385 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.575 |
MOD_CK1_1 | 212 | 218 | PF00069 | 0.647 |
MOD_CK1_1 | 365 | 371 | PF00069 | 0.632 |
MOD_CK2_1 | 118 | 124 | PF00069 | 0.654 |
MOD_CK2_1 | 189 | 195 | PF00069 | 0.732 |
MOD_CK2_1 | 223 | 229 | PF00069 | 0.566 |
MOD_CK2_1 | 31 | 37 | PF00069 | 0.487 |
MOD_CK2_1 | 340 | 346 | PF00069 | 0.556 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.515 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.462 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.612 |
MOD_GlcNHglycan | 186 | 189 | PF01048 | 0.729 |
MOD_GlcNHglycan | 191 | 194 | PF01048 | 0.680 |
MOD_GlcNHglycan | 304 | 308 | PF01048 | 0.388 |
MOD_GlcNHglycan | 367 | 370 | PF01048 | 0.565 |
MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.639 |
MOD_GSK3_1 | 114 | 121 | PF00069 | 0.543 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.498 |
MOD_GSK3_1 | 360 | 367 | PF00069 | 0.619 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.425 |
MOD_LATS_1 | 268 | 274 | PF00433 | 0.427 |
MOD_N-GLC_1 | 115 | 120 | PF02516 | 0.549 |
MOD_N-GLC_1 | 19 | 24 | PF02516 | 0.588 |
MOD_N-GLC_2 | 147 | 149 | PF02516 | 0.482 |
MOD_NEK2_1 | 129 | 134 | PF00069 | 0.555 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.530 |
MOD_NEK2_1 | 233 | 238 | PF00069 | 0.346 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.461 |
MOD_NEK2_1 | 58 | 63 | PF00069 | 0.426 |
MOD_PIKK_1 | 212 | 218 | PF00454 | 0.579 |
MOD_PIKK_1 | 340 | 346 | PF00454 | 0.442 |
MOD_PIKK_1 | 371 | 377 | PF00454 | 0.468 |
MOD_Plk_1 | 115 | 121 | PF00069 | 0.614 |
MOD_Plk_1 | 233 | 239 | PF00069 | 0.329 |
MOD_Plk_1 | 270 | 276 | PF00069 | 0.431 |
MOD_Plk_1 | 47 | 53 | PF00069 | 0.460 |
MOD_Plk_1 | 58 | 64 | PF00069 | 0.476 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.383 |
MOD_Plk_4 | 24 | 30 | PF00069 | 0.455 |
MOD_ProDKin_1 | 152 | 158 | PF00069 | 0.686 |
MOD_ProDKin_1 | 202 | 208 | PF00069 | 0.630 |
MOD_ProDKin_1 | 360 | 366 | PF00069 | 0.587 |
MOD_ProDKin_1 | 79 | 85 | PF00069 | 0.409 |
MOD_SUMO_rev_2 | 350 | 359 | PF00179 | 0.434 |
MOD_SUMO_rev_2 | 77 | 83 | PF00179 | 0.410 |
TRG_DiLeu_BaEn_1 | 327 | 332 | PF01217 | 0.379 |
TRG_ENDOCYTIC_2 | 230 | 233 | PF00928 | 0.519 |
TRG_Pf-PMV_PEXEL_1 | 290 | 294 | PF00026 | 0.291 |
TRG_Pf-PMV_PEXEL_1 | 73 | 77 | PF00026 | 0.368 |
TRG_Pf-PMV_PEXEL_1 | 93 | 97 | PF00026 | 0.380 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBE1 | Leptomonas seymouri | 66% | 100% |
A0A0S4JHH3 | Bodo saltans | 47% | 100% |
A0A1X0P5G2 | Trypanosomatidae | 56% | 100% |
A0A3S7X9G6 | Leishmania donovani | 91% | 100% |
A0A422P2T5 | Trypanosoma rangeli | 58% | 100% |
A4HMW4 | Leishmania braziliensis | 80% | 100% |
A4IBI5 | Leishmania infantum | 90% | 100% |
C9ZZ56 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
E9B6H6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
V5BD06 | Trypanosoma cruzi | 60% | 100% |